Home Health Psychedelic Drugmaker Definium Surges on Depression Drug Success
Health

Psychedelic Drugmaker Definium Surges on Depression Drug Success

Psychedelic Drugmaker Definium Surges on Depression Drug Success
Key Points

Psychedelic Drugmaker Definium Surges on Depression Drug Success Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders. Piper Sandler analyst David Amsellem said the latest data reinforce his view that the drug should emerge as a “best-in-class” option for patients with the disorder who haven’t had significant experience with...

Psychedelic Drugmaker Definium Surges on Depression Drug Success Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders. Piper Sandler analyst David Amsellem said the latest data reinforce his view that the drug should emerge as a “best-in-class” option for patients with the disorder who haven’t had significant experience with conventional treatments.
Psychedelic Drugmaker Definium (ORG) Depression Drug Success Psychedelic Drugmaker Definium (ORG) Depression Drug Success Definium Therapeutics Inc. (ORG) Piper Sandler (PERSON) David Amsellem (PERSON)
Originally published by Bloomberg Markets Read original →